Zimmer Biomet Holdings PE Ratio 2010-2025 | ZBH
Current and historical p/e ratio for Zimmer Biomet Holdings (ZBH) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zimmer Biomet Holdings PE ratio as of July 01, 2025 is 11.59.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Zimmer Biomet Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-01 | 94.06 | 20.81 | |
| 2025-03-31 | 112.89 | $4.52 | 24.98 |
| 2024-12-31 | 105.13 | $4.45 | 23.63 |
| 2024-09-30 | 107.20 | $5.26 | 20.38 |
| 2024-06-30 | 107.54 | $4.80 | 22.40 |
| 2024-03-31 | 130.48 | $4.62 | 28.24 |
| 2023-12-31 | 120.09 | $4.89 | 24.56 |
| 2023-09-30 | 110.52 | $2.26 | 48.90 |
| 2023-06-30 | 143.08 | $2.41 | 59.37 |
| 2023-03-31 | 126.75 | $2.14 | 59.23 |
| 2022-12-31 | 124.85 | $1.10 | 113.50 |
| 2022-09-30 | 102.18 | $1.32 | 77.41 |
| 2022-06-30 | 102.45 | $1.09 | 93.99 |
| 2022-03-31 | 124.44 | $1.03 | 120.82 |
| 2021-12-31 | 119.68 | $1.90 | 62.99 |
| 2021-09-30 | 137.62 | $3.89 | 35.38 |
| 2021-06-30 | 150.98 | $4.36 | 34.63 |
| 2021-03-31 | 150.06 | $2.69 | 55.79 |
| 2020-12-31 | 144.23 | $-0.71 | 0.00 |
| 2020-09-30 | 127.22 | $-0.76 | 0.00 |
| 2020-06-30 | 111.35 | $0.16 | 695.91 |
| 2020-03-31 | 94.10 | $1.81 | 51.99 |
| 2019-12-31 | 138.99 | $5.47 | 25.41 |
| 2019-09-30 | 127.27 | $-0.49 | 0.00 |
| 2019-06-30 | 108.97 | $-1.78 | 0.00 |
| 2019-03-31 | 117.94 | $-1.53 | 0.00 |
| 2018-12-31 | 95.61 | $-1.88 | 0.00 |
| 2018-09-30 | 120.90 | $8.70 | 13.90 |
| 2018-06-30 | 102.30 | $8.39 | 12.19 |
| 2018-03-31 | 99.87 | $8.39 | 11.90 |
| 2017-12-31 | 110.28 | $9.01 | 12.24 |
| 2017-09-30 | 106.80 | $3.18 | 33.58 |
| 2017-06-30 | 116.87 | $3.48 | 33.58 |
| 2017-03-31 | 110.93 | $2.42 | 45.84 |
| 2016-12-31 | 93.57 | $1.47 | 63.65 |
| 2016-09-30 | 117.61 | $1.28 | 91.88 |
| 2016-06-30 | 108.68 | $0.61 | 178.17 |
| 2016-03-31 | 96.07 | $-0.14 | 0.00 |
| 2015-12-31 | 92.22 | $0.36 | 256.17 |
| 2015-09-30 | 84.25 | $1.13 | 74.56 |
| 2015-06-30 | 97.75 | $1.98 | 49.37 |
| 2015-03-31 | 104.96 | $3.92 | 26.78 |
| 2014-12-31 | 101.11 | $4.19 | 24.13 |
| 2014-09-30 | 89.46 | $4.64 | 19.28 |
| 2014-06-30 | 92.21 | $4.58 | 20.13 |
| 2014-03-31 | 83.79 | $4.44 | 18.87 |
| 2013-12-31 | 82.37 | $4.43 | 18.59 |
| 2013-09-30 | 72.45 | $3.95 | 18.34 |
| 2013-06-30 | 65.94 | $4.07 | 16.20 |
| 2013-03-31 | 66.01 | $4.40 | 15.00 |
| 2012-12-31 | 58.33 | $4.29 | 13.60 |
| 2012-09-30 | 59.02 | $4.28 | 13.79 |
| 2012-06-30 | 56.02 | $4.27 | 13.12 |
| 2012-03-31 | 55.79 | $4.11 | 13.57 |
| 2011-12-31 | 46.23 | $4.02 | 11.50 |
| 2011-09-30 | 46.29 | $3.33 | 13.90 |
| 2011-06-30 | 54.70 | $3.28 | 16.68 |
| 2011-03-31 | 52.39 | $3.04 | 17.23 |
| 2010-12-31 | 46.46 | $2.97 | 15.64 |
| 2010-09-30 | 45.29 | $3.53 | 12.83 |
| 2010-06-30 | 46.78 | $3.27 | 14.31 |
| 2010-03-31 | 51.24 | $3.43 | 14.94 |
| 2009-12-31 | 51.16 | $3.33 | 15.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.046B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |